Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
22.67B | 23.77B | 22.62B | 20.79B | 22.37B | Gross Profit |
7.32B | 8.01B | 7.69B | 7.77B | 9.46B | EBIT |
3.35B | 3.98B | 3.31B | 3.74B | 5.24B | EBITDA |
4.43B | 5.14B | 4.12B | 4.55B | 6.02B | Net Income Common Stockholders |
2.30B | 2.80B | 1.93B | 3.27B | 4.59B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
14.32B | 18.22B | 18.70B | 18.26B | 20.60B | Total Assets |
39.80B | 40.22B | 42.34B | 42.29B | 44.44B | Total Debt |
13.11B | 14.27B | 17.07B | 18.26B | 20.86B | Net Debt |
-1.15B | -3.92B | -1.60B | 12.92M | 379.51M | Total Liabilities |
18.66B | 19.59B | 22.56B | 23.01B | 24.78B | Stockholders Equity |
20.92B | 20.40B | 19.52B | 19.04B | 19.41B |
Cash Flow | Free Cash Flow | |||
1.52B | 2.35B | 2.57B | 3.82B | 4.28B | Operating Cash Flow |
3.07B | 3.88B | 3.81B | 4.60B | 5.04B | Investing Cash Flow |
-110.26M | 3.58B | -6.07B | 2.68B | 1.56B | Financing Cash Flow |
-3.59B | -5.55B | -4.14B | -6.49B | -3.93B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | HK$26.57B | 30.26 | 37.28% | 2.54% | 59.83% | 68.29% | |
77 Outperform | €4.01B | 18.20 | 6.78% | 4.81% | 9.45% | 12.30% | |
73 Outperform | $25.51B | 10.05 | 11.12% | 8.23% | -6.53% | -18.43% | |
65 Neutral | $8.88B | 15.03 | 4.75% | 203.74% | 3.58% | -2.49% | |
63 Neutral | HK$427.87M | 7.69 | 12.01% | ― | 25.55% | 14.47% | |
55 Neutral | HK$656.15M | 10.48 | 8.96% | ― | 30.72% | -35.61% | |
54 Neutral | HK$25.14B | ― | -7.87% | 2.38% | 16.82% | -348.71% |
Hengan International Group Co has successfully issued the first tranche of its super short-term commercial papers, raising RMB1.0 billion with a coupon rate of 1.69% per annum. The proceeds will be used to supplement working capital and repay bank loans, enhancing the company’s financial stability and operational efficiency.
The most recent analyst rating on (HK:1044) stock is a Buy with a HK$40.00 price target. To see the full list of analyst forecasts on Hengan International Group Co stock, see the HK:1044 Stock Forecast page.
Hengan International Group Co announced that all resolutions proposed at their Annual General Meeting (AGM) held on May 20, 2025, were passed by shareholders. Key resolutions included the approval of audited accounts, declaration of a final dividend, re-election of directors, re-appointment of auditors, and granting of mandates to the board for share repurchase and issuance. The successful passing of these resolutions indicates strong shareholder support and positions the company for continued operational stability and strategic growth.
The most recent analyst rating on (HK:1044) stock is a Buy with a HK$40.00 price target. To see the full list of analyst forecasts on Hengan International Group Co stock, see the HK:1044 Stock Forecast page.
Hengan International Group Co announced the passing of its Deputy Chairman and Executive Director, Mr. Hui Lin Chit, who was a founder and instrumental in the company’s growth. Despite his passing, the board assures stakeholders that the company’s operations will remain unaffected and they will continue to focus on strengthening and developing the group.
Hengan International Group Co has announced its Annual General Meeting (AGM) scheduled for May 20, 2025, in Hong Kong. Key agenda items include the consideration of audited accounts, declaration of a final dividend, re-election of directors, and re-appointment of auditors. Additionally, a resolution will be proposed to authorize the company to repurchase up to 10% of its issued shares, which could impact shareholder value and market perception.